I help life sciences companies with licensing, partnering and other technology based transactions.
查看中文
bwang@cooley.com
Bin Wang is a corporate special counsel in the life sciences practice. His practice focuses on the representation of technology companies, primarily in the life sciences industry.
Download full bio
Shoreline Enters Partnership with Kite
Shoreline Enters Collaboration with BeiGene
Versartis $145 Million IPO
Adamas Pharmaceuticals Initial Public Offering
Atara – $63 Million IPO and Follow-On Offerings
View all
Life Sciences Corporate Partnering & Licensing
Life Sciences
Asia
Spending time with family
University of Pennsylvania Law SchoolJD, 2008
University of UtahPhD, Biochemistry2003
Utah State UniversityMS, Computer Science2002
University of Science and Technology of ChinaBS, Biology1996
California
Shoreline Biosciences Enters Collaboration With BeiGene to Develop Genetically Modified Cell Therapies June 24, 2021
CStone Enters Exclusive Collaboration With Blueprint Medicines June 26, 2018
ASLAN Pharmaceuticals – $42 Million IPO June 8, 2018
+1 650 843 5032
Locations